Memantine vs Trastuzumab
Memantine vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Memantine and Trastuzumab.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Memantine β 60-80 hours; Trastuzumab β 28 days.
Chemical Properties
Molecular Formula: Memantine β C12H21N.
Molecular Weight: Memantine β 179.3080 g/mol.
Type: Memantine β Small molecule; Trastuzumab β Antibody.